MOXAVAL-CL 625 Tablet
Broad-Spectrum Antibiotic for Resistant Infections
Composition
Amoxicillin 500 mg + Potassium Clavulanate 125 mg
- Pack: 10 x 10 Tablets
- Prescription medicine
- Available to order
Overview
MOXAVAL-CL 625 combines Amoxicillin, a broad-spectrum penicillin antibiotic, with Potassium Clavulanate, a β-lactamase inhibitor, to enhance the effectiveness of Amoxicillin against bacteria that produce β-lactamase enzymes. This combination therapy provides potent antibacterial action against a variety of infections, ensuring optimal therapeutic outcomes.
Key Benefits
- Provides broad-spectrum coverage against both gram-positive and gram-negative bacteria
- Overcomes bacterial resistance caused by β-lactamase-producing organisms
- Effective for treating respiratory, urinary, and skin infections
- Convenient dosage formulation for improved patient compliance
- Well-tolerated with a favorable safety profile
Indications
- Respiratory tract infections (e.g., pneumonia, bronchitis, sinusitis)
- Urinary tract infections (e.g., cystitis, pyelonephritis)
- Skin and soft tissue infections (e.g., cellulitis, abscesses)
- Otitis media, tonsillitis, and other ENT infections
